Skip to main content
Filters

    Results for RNA ( 545 )

      • Ref: WM983C-04-1000
        Sizes: 25 µg

        Total RNA was prepared from cell line WM983C. WM983C is a metastatic human melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type PTEN, N-RAS, c-KIT, and CDK4 genes. WM983 cells produce xenograft tumors when injected into immunocompromised mice.

        Product detail
      • Ref: WM989-04-0200
        Sizes: 5 µg

        Total RNA was prepared from cell line WM989. WM989 is a melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type N-RAS, c-KIT, and CDK4 genes. WM989 cells produce xenograft tumors when injected into immunocompromised mice.

        Product detail
      • Ref: WM989-04-0500
        Sizes: 10 µg

        Total RNA was prepared from cell line WM989. WM989 is a melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type N-RAS, c-KIT, and CDK4 genes. WM989 cells produce xenograft tumors when injected into immunocompromised mice.

        Product detail
      • Ref: WM989-04-1000
        Sizes: 25 µg

        Total RNA was prepared from cell line WM989. WM989 is a melanoma cell line. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type N-RAS, c-KIT, and CDK4 genes. WM989 cells produce xenograft tumors when injected into immunocompromised mice.

        Product detail